Merck & Co., Inc.
MRK
$92.93
$1.481.62%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.79B | 4.43B | 5.08B | 3.74B | 3.16B |
| Total Depreciation and Amortization | 1.10B | 1.06B | 1.06B | 1.11B | 1.15B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -375.00M | 61.00M | 75.00M | 448.00M | 2.41B |
| Change in Net Operating Assets | 1.31B | -2.26B | -3.71B | -1.86B | 2.58B |
| Cash from Operations | 7.82B | 3.29B | 2.50B | 3.45B | 9.29B |
| Capital Expenditure | -987.00M | -764.00M | -1.33B | -937.00M | -783.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -2.00M | -3.35B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 704.00M | -6.00M | -159.00M | -505.00M | 283.00M |
| Cash from Investing | -283.00M | -770.00M | -1.49B | -1.44B | -3.85B |
| Total Debt Issued | 5.98B | 48.00M | -- | 0.00 | -1.00M |
| Total Debt Repaid | -1.00M | 0.00 | -2.50B | -539.00M | 0.00 |
| Issuance of Common Stock | 14.00M | 12.00M | 19.00M | 12.00M | 5.00M |
| Repurchase of Common Stock | -1.32B | -1.35B | -1.16B | -489.00M | -444.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.03B | -2.08B | -2.05B | -1.95B | -1.95B |
| Other Financing Activities | 2.00M | -194.00M | -60.00M | -42.00M | -32.00M |
| Cash from Financing | 2.64B | -3.56B | -5.76B | -3.01B | -2.43B |
| Foreign Exchange rate Adjustments | 10.00M | 374.00M | 156.00M | -367.00M | 294.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.19B | -659.00M | -4.59B | -1.37B | 3.32B |